Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
Por um escritor misterioso
Descrição
A Novel C-C Chemoattractant Cytokine (Chemokine) Receptor 6 (CCR6) Antagonist (PF-07054894) Distinguishes between Homologous Chemokine Receptors, Increases Basal Circulating CCR6+ T Cells, and Ameliorates Interleukin-23-Induced Skin Inflammation
Urotensin II Receptor Modulation with 1,3,4-Benzotriazepin-2-one Tetrapeptide Mimics
Novel peptide nanoparticle–biased antagonist of CCR3 blocks eosinophil recruitment and airway hyperresponsiveness - ScienceDirect
Structural Analysis of Chemokine Receptor–Ligand Interactions
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities
KR100837019B1 - 3-4-heteroarylcyclohexylaminocyclopentanecarboxamides as modulators of chemokine receptors - Google Patents
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2 (CCR2) Antagonists
Discovery of BMS-753426: A Potent Orally Bioavailable Antagonist of CC Chemokine Receptor 2
Small molecules in the treatment of COVID-19
Small molecules in the treatment of COVID-19
Selective and Dual Targeting of CCR2 and CCR5 Receptors: A Current Overview
WO2015004534A2 - Novel substituted bicyclic compounds as bromodomain inhibitors - Google Patents
CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV. - Abstract - Europe PMC
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities
de
por adulto (o preço varia de acordo com o tamanho do grupo)
